Abstract
Objective:
The pathophysiologies of bronchopulmonary dysplasia (BPD) are inflammation, infection, tissue damage, angiogenesis defects and genetic susceptibility. Because of the role of the vitamin D binding protein (Gc globulin) on these factors, we investigated the relationship between Gc globulin polymorphisms and BPD.
Study design:
This case-control study was performed with 160 neonates (⩽32 gestational ages, ⩽1500 g). PCR DNA sequence analyses were used for GC gene rs4588 and rs7041 single-nucleotide polymorphisms.
Result:
In the univariate analyses, it was observed that Gc2 was the only variant that was protective against BPD (Odd ratio (OR)=0.47, 95% coinfidence interval (CI)=0.24 to 0.89, P=0.020). In the multivariate analyses, Gc2 decreased the risk of disease (OR=0.15, 95% CI=0.029 to 0.79, P=0.026) independent of gestational age, birth weight, 5-min Appearance, Pulse, Grimace, Activity, and Respiration scores, respiratory distress syndrome and sepsis.
Conclusion:
The Gc2 variant was, after adjusting for confounders, associated with a decrease in the frequency of BPD. Our study adds Gc globulin to the list of candidate genes that potentially contribute to the etiology of the disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fanaroff AA, Hack M, Walsh MC . The NICHD neonatal research network: changes in practice and outcomes during the first 15 years. Semin Perinatol 2003; 27: 281–287.
Bhandari V, Gruen JR . The genetics of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 185–191.
Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM . Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 164: 1971–1980.
Deakins KM . Bronchopulmonary dysplasia. Respir Care 2009; 54: 1252–1262.
Lavoie PM, Dube MP . Genetics of bronchopulmonary dysplasia in the age of genomics. Curr Opin Pediatr 2010; 22: 134–138.
Shaw EM, O’ Brodovich HM . Progress in understanding the genetics of bronchopulmonary dysplasia. Semin Perinatol 2013; 37: 85–93.
Chishimba L, Thickett DR, Stockley RA, Wood AM . The vitamin D axis in the lung: a key role for vitamin D-binding protein. Thorax 2010; 65: 456–462.
Speeckaert M, Huang G, Delanghe JR, Taes YE . Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 2006; 372: 33–42.
Koroglu OA, Onay H, Cakmak B, Bilgin B, Yalaz M, Tunc S et al. Association of vitamin D receptor gene polymorphisms and bronchopulmonary dysplasia. Pediatr Res 2014; 76: 171–176.
Gozdzik A, Zhu J, Wong BY, Fu L, Cole DE, Parra EJ . Association of vitamin D binding protein (VDBP) polymorphisms and serum 25(OH) D concentrations in a sample of young Canadian adults of different ancestry. J Steroid Biochem Mol Biol 2011; 127: 405–412.
Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D binding gene. Thorax 2010; 65: 215–220.
Fu L, Yun F, Oczak M, Wong BY, Vieth R, Cole DE . Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH) D] to vitamin D supplementation. Clin Biochem 2009; 42: 1174–1177.
Jobe AH, Bancalari E . Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723–1729.
Agostoni C, Buonocore G, Carnielli VP, De Curtis M, Darmaun D, Decsi T et al. Enteral nutrient supply for preterm infants; commentary from the European Society of Pediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. JPGN 2010; 50: 85–91.
Somaschini M, Castiglioni E, Presi S, Volonteri C, Ferrari M, Carrera P . Genetic susceptibility to neonatal lung diseases. Acta Biomed 2012; 83 (Suppl 1): 10–14.
Hollams EM, Hart PH, Holt BJ, Serralha M, Parsons F, de Klerk NH et al. Vitamin D and atopy and asthma phenotypes in children; a longitidunal cohort study. Eur Respir J 2011; 38: 1320–1327.
Navas-Nazario A, Li FY, Shabanova V, Weiss P, Cole DE, Carpenter TO et al. Effect of vitamin D-binding protein genotype on the development of asthma in children. Ann of Allergy Asthma, and Immunol 2014; 112: 519–524.
Agarwal R, Virmani D, Jaipal ML, Gupta S, Gupta N, Sankar MJ et al. Vitamin D status of low birth weight infants in Delhi: a comperative study. J Trop Pediatr 2012; 58: 446–450.
Hypoonen E, Sovio U, Wjst M, Patel S, Pekkanen J, Hartikainen AL et al. Infant vitamin d supplementation and allergic conditions in adulthood; Northern Finland birth cohort 1966. Ann New York Acad Sci 2004; 1037: 84–95.
Camargo CA Jr, Ingham T, Wickens K, Thadhani R, Silvers KM, Epton MJ et al. Cord blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing and asthma. Pediatrics 2011; 127: e180–e187.
Carpenter TO, Zhang JH, Parra E, Ellis BK, Simpson C, Lee WM et al. Vitamin D binding globulin is a key determinant of 25-hydroxyvitamin D levels in infants and toddlers. J Bone and Miner Res 2013; 28: 213–221.
Li F, Jiang L, Willis- Owen SA, Zhang Y, Gao J . Vitamin D binding protein variants associate with asthma in susceptibility in the Chinese Han population. BMC Med Genet 2011; 12: 103.
Rejnmark L, Lauridsen AL, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L . Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to plasma parathyroid hormone and calcium and phosphate metabolism. Eur J Endocrinol 2002; 146: 635–642.
Chess PR, D’ Angio CT, Pryhuber GS, Maniscalco WM . Pathogenesis of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 171–178.
Lykkedegn S, Sorensen GL, Beck-Nielsen SS, Christesen HT . The impact of vitamin D on fetal and neonatal lung maturation. A systematic review. Am J Physiol Lung Cell Mol Physiol 2015; 308: L587–L602 ajplung.00117.2014.
Albert DM, Scheef EA, Wang S, Mehraein F, Darjatmoko SR, Sorenson CM et al. Calcitriol is a potent inhibitor of retinal neovascularization. IOVS 2007; 5: 2327–2334.
Cardus A, Panizo S, Encinas M, Dolcet X, Gallego C, Aldea M et al. 1,25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis 2009; 204: 85–89.
Kanda S, Mochizuki Y, Miyata Y, Kanetake H, Yamamoto N . Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis. J Natl Cancer Inst 2002; 94: 1311–1319.
Trembath A, Laughon MM . Predictors of bronchopulmonary dysplasia. Clin Perinatol 2012; 39: 585–601.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Serce Pehlevan, O., Karatekin, G., Koksal, V. et al. Association of vitamin D binding protein polymorphisms with bronchopulmonary dysplasia: a case–control study of gc globulin and bronchopulmonary dysplasia. J Perinatol 35, 763–767 (2015). https://doi.org/10.1038/jp.2015.58
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2015.58
This article is cited by
-
Potential role of vitamin D receptor-related polymorphisms in bronchopulmonary dysplasia
Egyptian Journal of Medical Human Genetics (2021)